Crime & Safety
Delco Company To Pay $17M For False Medicare Claim Allegations
Pentec billed federal programs for excessive amounts of product wasted during the compounding of a renal drug, federal authorities said.

GLEN MILLS, PA — A Delaware County-based company that makes provide pharmaceutical services has been ordered to pay millions after being accused of submitting false claims to Medicare and other government healthcare programs.
U.S. Attorney William M. McSwain announced that Pentec Health, Inc. has agreed to pay the United States $17 million to settle allegations that Pentec submitted false claims to Medicare and other government healthcare programs.
Headquartered in Glen Mills, Delaware County, Pentec furnishes a range of renal and specialized pharmacy compounding services, including the compounding of its drug, Proplete, and the provision of intradialytic parenteral nutrition and intraperitoneal nutrition to individuals with end stage renal disease.
Find out what's happening in Marple Newtownfor free with the latest updates from Patch.
The United States alleges that from 2007 to 2018, Pentec billed Medicare and other federal healthcare programs for excessive amounts of product wasted during the compounding of Proplete, and Pentec routinely waived patient copayments and deductible obligations in order to induce the prescription and use of Proplete.
Pentec also submitted duplicate and improperly coded claims to the Federal Employee Health Benefits Program.
Find out what's happening in Marple Newtownfor free with the latest updates from Patch.
Along with this Settlement, Pentec has also signed a Corporate Integrity Agreement with the Department of Health and Human Services, Office of Inspector General.
The company is subject to exclusion from Federal health care programs, including Medicare and Medicaid, for a material breach of this CIA and subject to monetary penalties for less significant breaches for a period of five years.
This settlement resolves a lawsuit filed under the False Claims Act (FCA) in the U.S. District Court for the Eastern District of Pennsylvania by Jean Brasher, a former employee of Pentec, under the qui tam or whistleblower provisions of the FCA, which permit private citizens to bring lawsuits on behalf of the United States and obtain a portion of the government’s recovery.
Tips and complaints from all sources about potential fraud, waste, abuse, and mismanagement can be reported to the Department of Health and Human Services at (800) 447-8477.
The claims resolved by this settlement are allegations only and there has been no determination of liability.
Image via Shutterstock
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.